We report a rare case of carbapenemase-producing enterobacte-riaceae peritonitis in a patient undergoing automated peritoneal dialysis (APD). The PD catheter had to be removed as the patient remained unwell despite antibiotics. Antimicrobial resistance in PD peritonitis is a concern in this era of multi-drug resistant bacteria.
Van DuinD., DoiY.The global epidemiology of carbapenemase-producing enterobacteriaceae.Virulence2017; 8(4): 460–9.
2.
ChewK.L., LinR.T.P., TeoJ.W.P.Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat.Front Cell Infect Microbiol2017; 7: 515.
3.
TolemanM.A.The future of peritoneal dialysis in a moving landscape of bacterial resistance.Perit Dial Int2017; 37(2): 134–40.
4.
CheungC.Y., ChanS.Y., YeungC.S., ChakW.L., WuT.C., ChauK.F.Carbapenem-resistant enterobacteriaceae as a cause of peritonitis in a peritoneal dialysis patient.Nephrology (Carlton)2016; 21(10): 906–7.
5.
VillegasM.V., PallaresC.J., Escandon-VargasK., Hernandez-GomezC., CorreaA., AlvarezC.Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing enterobacteriaceae in seven Latin American countries.PLOS One2016; 11(4).
6.
HusseinK., Raz-PasteurA., FinkelsteinR., NeubergerA., Shachor-MeyouhasY., OrenI.Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae.J Hosp Infect2013; 83(4): 307–13.
